Business Description
Philogen Spa
NAICS : 325412
Compare
Compare
Traded in other countries / regions
78Q.GermanyPHIL.Italy IPO Date
2021-03-08Description
Philogen Spa is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, it derives a majority of revenue from the USA.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.15 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | -15.71 | |||||
| Piotroski F-Score | N/A/9 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.2 | |||||
| 9-Day RSI | 50.1 | |||||
| 14-Day RSI | 52.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.31 | |||||
| Quick Ratio | 7.18 | |||||
| Cash Ratio | 6.38 | |||||
| Days Inventory | 45.09 | |||||
| Days Sales Outstanding | 13.21 | |||||
| Days Payable | 180.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.19 | |||||
| Operating Margin % | -0.6 | |||||
| Net Margin % | -26.75 | |||||
| ROE % | -4.72 | |||||
| ROA % | -3.73 | |||||
| ROIC % | -0.6 | |||||
| ROC (Joel Greenblatt) % | -14.98 | |||||
| ROCE % | -2.52 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 32.67 | |||||
| PB Ratio | 5.85 | |||||
| Price-to-Tangible-Book | 5.98 | |||||
| EV-to-EBIT | -170.4 | |||||
| EV-to-EBITDA | -693.58 | |||||
| EV-to-Revenue | 27.99 | |||||
| EV-to-FCF | -61.72 | |||||
| Price-to-Net-Current-Asset-Value | 7.69 | |||||
| Price-to-Net-Cash | 9.31 | |||||
| Earnings Yield (Greenblatt) % | -0.59 |
How Philogen Spa (STU:78Q) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
Details
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 19.033 | ||
| EPS (TTM) (€) | -0.12 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 52.4 | ||
| 14-Day ATR (€) | 0.369822 | ||
| 20-Day SMA (€) | 15.781 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 14.36 - 16.5 | ||
| Shares Outstanding (Mil) | 40.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Philogen Spa Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Philogen Spa Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Philogen Spa Frequently Asked Questions
What is Philogen Spa(STU:78Q)'s stock price today?
The current price of STU:78Q is €15.04. The 52 week high of STU:78Q is €16.50 and 52 week low is €14.36.
When is next earnings date of Philogen Spa(STU:78Q)?
The next earnings date of Philogen Spa(STU:78Q) is .
Does Philogen Spa(STU:78Q) pay dividends? If so, how much?
Philogen Spa(STU:78Q) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
